Integrated DNA Technologies (IDT) has launched a preferred sequencing provider program with McDonnell Genome Institute (MGI) at Washington University.
Integrated DNA Technologies (IDT) has announced an expansion to its next generation sequencing (NGS portfolio) with the launch of Custom NGS Adapters that are designed to provide an easy and flexible customised adapter solution directly to scientists
Aldevron, a contract development and manufacturing organisation serving the biotech industry, has announced the release of GMP SpyFi Cas9 Nuclease for clinical and commercial applications
Demonstrating its commitment to science advocacy and sustainability, Integrated DNA Technologies (IDT), is now inviting applications for its 2017 Sustainability Award program with a prize pool of more than $50,000
Caribou Biosciences, a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies (IDT), a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialise CRISPR-Cas9 reagents under Caribous intellectual property
Integrated DNA Technologies (IDT) is providing free oligo design and analysis tools via its online SciTools suite
Integrated DNA Technologies (IDT) and Rensselaer Polytechnic Institute (RPI) have launched the UNAFold secondary structure prediction software
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
